0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Colorectal Cancer
 101-120 of 138 Articles
Medical News and Perspectives | 
M.J. Friedrich
JAMA. 2004;292(6):671-673. doi:10.1001/jama.292.6.671.

Special Communication | 
Louise C. Walter, MD; Natalie P. Davidowitz, BA; Paul A. Heineken, MD; et al.
JAMA. 2004;291(20):2466-2470. doi:10.1001/jama.291.20.2466.

Editorial | 
Stephen B. Hulley, MD, MPH; Deborah Grady, MD, MPH
JAMA. 2004;291(14):1769-1771. doi:10.1001/jama.291.14.1769.

Editorial | 
Boris Pasche, MD, PhD; Charles N. Serhan, PhD
JAMA. 2004;291(5):623-624. doi:10.1001/jama.291.5.623.

Original Contribution |  FREE
Thomas P. Erlinger, MD, MPH; Elizabeth A. Platz, ScD, MPH; Nader Rifai, PhD; et al.
JAMA. 2004;291(5):585-590. doi:10.1001/jama.291.5.585.

Original Contribution |  FREE
David A. Lieberman, MD; Sheila Prindiville, MD, MPH; David G. Weiss, PhD; et al.
JAMA. 2003;290(22):2959-2967. doi:10.1001/jama.290.22.2959.

Clinical Investigation |  FREE
Loïc Le Marchand, MD, PhD; Ann Seifried, BA; Annette Lum-Jones, BS; et al.
JAMA. 2003;290(21):2843-2848. doi:10.1001/jama.290.21.2843.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2003;289(19):2492-2493. doi:10.1001/jama.289.19.2492.

Medical News and Perspectives | 
Brian Vastag
JAMA. 2003;289(15):1912. doi:10.1001/jama.289.15.1912.

Original Contribution |  FREE
Brenda E. Sirovich, MD, MS; Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS
JAMA. 2003;289(11):1414-1420. doi:10.1001/jama.289.11.1414.

Scientific Review and Clinical Applications |  FREE
Judith M. E. Walsh, MD, MPH; Jonathan P. Terdiman, MD
JAMA. 2003;289(10):1288-1296. doi:10.1001/jama.289.10.1288.

Scientific Review and Clinical Applications |  FREE
Judith M. E. Walsh, MD, MPH; Jonathan P. Terdiman, MD
JAMA. 2003;289(10):1297-1302. doi:10.1001/jama.289.10.1297.

JAMA Patient Page |  FREE
JAMA. 2003;289(10):1334. doi:10.1001/jama.289.10.1334.

Medical News and Perspectives | 
Mike Mitka
JAMA. 2003;289(9):1089-1090. doi:10.1001/jama.289.9.1089.

From the Food and Drug Administration | 
Lester M. Crawford, Jr, DVM, PhD
JAMA. 2002;288(10):1225. doi:10.1001/jama.288.10.1225.

Scientific Review and Clinical Applications |  FREE
Heidi D. Nelson, MD, MPH; Linda L. Humphrey, MD, MPH; Peggy Nygren, MA; et al.
JAMA. 2002;288(7):872-881. doi:10.1001/jama.288.7.872.

Quick Uptakes | 
Mike Mitka
JAMA. 2002;288(4):441. doi:10.1001/jama.288.4.441-JQU20007-3-1.

Original Contribution |  FREE
Writing Group for the Women's Health Initiative Investigators
JAMA. 2002;288(3):321-333. doi:10.1001/jama.288.3.321.

Quick Uptakes | 
Mike Mitka
JAMA. 2002;287(20):2645. doi:10.1001/jama.287.20.2645.

Original Contribution |  FREE
Jane C. Weeks, MD; Heidi Nelson, MD; Shari Gelber, MS; et al.
JAMA. 2002;287(3):321-328. doi:10.1001/jama.287.3.321.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab A Fresh Approach to an Old Puzzle
Elizabeth C. Smyth, MB, BCh, MSc; Khurum Khan, MBBS; David Cunningham, FMedSci
JAMA Oncology
Original Investigation  | 
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer
Jenny F. Seligmann, PhD; Faye Elliott, MSc; Susan D. Richman, PhD; et al.
JAMA Oncology
Invited Commentary  | 
Biomarkers of Fluorouracil Toxicity Insight From the PETACC-8 Trial
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncology
Original Investigation  | 
DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer A Secondary Analysis of the PETACC-8 Randomized Clinical Trial
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.